vs

Side-by-side financial comparison of C4 Therapeutics, Inc. (CCCC) and Where Food Comes From, Inc. (WFCF). Click either name above to swap in a different company.

C4 Therapeutics, Inc. is the larger business by last-quarter revenue ($11.0M vs $6.0M, roughly 1.8× Where Food Comes From, Inc.). Where Food Comes From, Inc. runs the higher net margin — -3.4% vs -186.0%, a 182.6% gap on every dollar of revenue. On growth, C4 Therapeutics, Inc. posted the faster year-over-year revenue change (112.8% vs -9.3%). Over the past eight quarters, C4 Therapeutics, Inc.'s revenue compounded faster (90.4% CAGR vs 4.0%).

C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted protein degradation therapies for cancer and other severe diseases with high unmet medical needs. It leverages its proprietary TORPEDO platform to design small molecule degraders that eliminate disease-causing proteins, with a pipeline of oncology candidates in preclinical and clinical development, plus strategic partnerships with leading global pharmaceutical firms.

Where Food Comes From, Inc. is a leading provider of food traceability, verification, and certification solutions for the agricultural and food production industries. Its services support producers, processors, and retailers across North America to validate food origin, sustainability practices, animal welfare standards, and product authenticity for end consumers.

CCCC vs WFCF — Head-to-Head

Bigger by revenue
CCCC
CCCC
1.8× larger
CCCC
$11.0M
$6.0M
WFCF
Growing faster (revenue YoY)
CCCC
CCCC
+122.1% gap
CCCC
112.8%
-9.3%
WFCF
Higher net margin
WFCF
WFCF
182.6% more per $
WFCF
-3.4%
-186.0%
CCCC
Faster 2-yr revenue CAGR
CCCC
CCCC
Annualised
CCCC
90.4%
4.0%
WFCF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCCC
CCCC
WFCF
WFCF
Revenue
$11.0M
$6.0M
Net Profit
$-20.5M
$-203.0K
Gross Margin
35.9%
Operating Margin
-210.1%
-1.0%
Net Margin
-186.0%
-3.4%
Revenue YoY
112.8%
-9.3%
Net Profit YoY
40.7%
-121.1%
EPS (diluted)
$-0.09
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCCC
CCCC
WFCF
WFCF
Q4 25
$11.0M
$6.0M
Q3 25
$11.2M
$7.0M
Q2 25
$6.5M
$6.6M
Q1 25
$7.2M
$5.3M
Q4 24
$5.2M
$6.7M
Q3 24
$15.4M
$7.1M
Q2 24
$12.0M
$6.4M
Q1 24
$3.0M
$5.6M
Net Profit
CCCC
CCCC
WFCF
WFCF
Q4 25
$-20.5M
$-203.0K
Q3 25
$-32.2M
$1.1M
Q2 25
$-26.0M
$562.0K
Q1 25
$-26.3M
$31.0K
Q4 24
$-34.6M
$961.0K
Q3 24
$-24.7M
$492.0K
Q2 24
$-17.7M
$489.0K
Q1 24
$-28.4M
$178.0K
Gross Margin
CCCC
CCCC
WFCF
WFCF
Q4 25
35.9%
Q3 25
38.3%
Q2 25
37.5%
Q1 25
41.6%
Q4 24
42.0%
Q3 24
39.0%
Q2 24
41.6%
Q1 24
41.7%
Operating Margin
CCCC
CCCC
WFCF
WFCF
Q4 25
-210.1%
-1.0%
Q3 25
-306.4%
8.2%
Q2 25
-441.0%
8.4%
Q1 25
-402.9%
2.7%
Q4 24
-728.4%
11.3%
Q3 24
-183.9%
8.6%
Q2 24
-178.6%
9.1%
Q1 24
-1060.2%
4.7%
Net Margin
CCCC
CCCC
WFCF
WFCF
Q4 25
-186.0%
-3.4%
Q3 25
-286.4%
16.3%
Q2 25
-402.6%
8.6%
Q1 25
-363.7%
0.6%
Q4 24
-667.8%
14.4%
Q3 24
-160.6%
6.9%
Q2 24
-147.6%
7.6%
Q1 24
-933.2%
3.2%
EPS (diluted)
CCCC
CCCC
WFCF
WFCF
Q4 25
$-0.09
$-0.04
Q3 25
$-0.44
$0.22
Q2 25
$-0.37
$0.11
Q1 25
$-0.37
$0.01
Q4 24
$-0.50
$0.19
Q3 24
$-0.35
$0.09
Q2 24
$-0.26
$0.09
Q1 24
$-0.41
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCCC
CCCC
WFCF
WFCF
Cash + ST InvestmentsLiquidity on hand
$74.6M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$256.6M
$9.3M
Total Assets
$359.1M
$12.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCCC
CCCC
WFCF
WFCF
Q4 25
$74.6M
$3.2M
Q3 25
$58.8M
$4.8M
Q2 25
$78.2M
$3.2M
Q1 25
$51.3M
$2.2M
Q4 24
$55.5M
$2.0M
Q3 24
$59.6M
$2.8M
Q2 24
$73.1M
$2.6M
Q1 24
$89.7M
$1.9M
Stockholders' Equity
CCCC
CCCC
WFCF
WFCF
Q4 25
$256.6M
$9.3M
Q3 25
$154.4M
$10.3M
Q2 25
$174.1M
$10.0M
Q1 25
$195.1M
$9.6M
Q4 24
$216.0M
$9.9M
Q3 24
$242.7M
$9.5M
Q2 24
$247.1M
$9.7M
Q1 24
$258.3M
$9.6M
Total Assets
CCCC
CCCC
WFCF
WFCF
Q4 25
$359.1M
$12.9M
Q3 25
$265.5M
$16.9M
Q2 25
$296.5M
$16.6M
Q1 25
$319.5M
$15.2M
Q4 24
$349.6M
$15.3M
Q3 24
$376.1M
$16.9M
Q2 24
$381.1M
$16.8M
Q1 24
$398.4M
$15.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCCC
CCCC
WFCF
WFCF
Operating Cash FlowLast quarter
$-22.1M
$-707.0K
Free Cash FlowOCF − Capex
$-741.0K
FCF MarginFCF / Revenue
-12.3%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCCC
CCCC
WFCF
WFCF
Q4 25
$-22.1M
$-707.0K
Q3 25
$-31.2M
$501.0K
Q2 25
$-12.1M
$1.2M
Q1 25
$-33.3M
$632.0K
Q4 24
$-17.9M
$-50.0K
Q3 24
$-24.1M
$912.0K
Q2 24
$-5.0M
$1.2M
Q1 24
$-18.1M
$700.0K
Free Cash Flow
CCCC
CCCC
WFCF
WFCF
Q4 25
$-741.0K
Q3 25
$-31.6M
$443.0K
Q2 25
$1.1M
Q1 25
$603.0K
Q4 24
$-17.9M
$-79.0K
Q3 24
$-24.1M
$873.0K
Q2 24
$-5.2M
$1.1M
Q1 24
$676.0K
FCF Margin
CCCC
CCCC
WFCF
WFCF
Q4 25
-12.3%
Q3 25
-281.5%
6.3%
Q2 25
17.5%
Q1 25
11.4%
Q4 24
-346.5%
-1.2%
Q3 24
-157.2%
12.3%
Q2 24
-43.1%
17.2%
Q1 24
12.1%
Capex Intensity
CCCC
CCCC
WFCF
WFCF
Q4 25
0.6%
Q3 25
3.7%
0.8%
Q2 25
0.5%
Q1 25
0.5%
Q4 24
0.1%
0.4%
Q3 24
0.1%
0.5%
Q2 24
1.6%
1.0%
Q1 24
0.0%
0.4%
Cash Conversion
CCCC
CCCC
WFCF
WFCF
Q4 25
Q3 25
0.44×
Q2 25
2.10×
Q1 25
20.39×
Q4 24
-0.05×
Q3 24
1.85×
Q2 24
2.39×
Q1 24
3.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCCC
CCCC

Segment breakdown not available.

WFCF
WFCF

Verification And Certification Service Revenue$5.0M83%
Other$1.0M17%

Related Comparisons